RESPIMAT Trademark

Trademark Overview

On Monday, September 15, 2008, a trademark application was filed for RESPIMAT with the United States Patent and Trademark Office. The USPTO has given the RESPIMAT trademark a serial number of 79074741. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, September 16, 2018. This trademark is owned by Boehringer Ingelheim International GmbH. The RESPIMAT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for pharmaceutical products
respimat

General Information

Serial Number79074741
Word MarkRESPIMAT
Filing DateMonday, September 15, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, September 16, 2018
Registration Number3864434
Registration DateTuesday, October 19, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 3, 2010

Trademark Statements

Goods and ServicesConducting clinical trials for pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 26, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, April 5, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, April 5, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, March 2, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 2, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 2, 2018INVALIDATION PROCESSED
Friday, January 26, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 26, 2017CANCELLED SECTION 71
Saturday, February 12, 2011FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 21, 2011FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 21, 2011FINAL DISPOSITION PROCESSED
Wednesday, January 19, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 19, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, August 10, 2010ASSIGNED TO EXAMINER
Tuesday, August 3, 2010PUBLISHED FOR OPPOSITION
Wednesday, July 14, 2010NOTICE OF PUBLICATION
Tuesday, June 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 21, 2010EXAMINERS AMENDMENT MAILED
Monday, June 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 21, 2010EXAMINER'S AMENDMENT ENTERED
Monday, June 21, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 16, 2010AMENDMENT FROM APPLICANT ENTERED
Wednesday, June 16, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 16, 2010ASSIGNED TO LIE
Friday, June 4, 2010PAPER RECEIVED
Tuesday, March 2, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 8, 2010REFUSAL PROCESSED BY IB
Thursday, December 3, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 3, 2009REFUSAL PROCESSED BY MPU
Thursday, December 3, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 2, 2009NON-FINAL ACTION WRITTEN
Wednesday, December 2, 2009APPLICATION FILING RECEIPT MAILED
Saturday, November 28, 2009ASSIGNED TO EXAMINER
Saturday, November 28, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 26, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

respimat products pharmaceutical trials clinical conducting